Categoría: OTCQB:RLLVF

Auto Agregado por WPeMatico


Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to announce that Biocannabix Health Corporation (“Biocannabix”), a wholly-owned subsidiary of Relevium has executed on June 12, 2019 a binding agreement to acquire the shares of Lifeline Pharma Read more…


Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that it has closed a non-brokered private placement financing for a total of 15,350,000 units (the “Units”) at $0.08 per Unit, for total gross proceeds of $1,228,000. Read more…


Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s positioning and strategy regarding medical cannabis and CBD Nutraceuticals. LEEFYLYFETM BRAND OF HEMP CBD FORMULATIONS United States The Food and Drug Read more…


Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary Biocannabix Health Corporation Inc., has completed necessary compliance process and obligations for the acquisition for exclusive licensing with cannabis company Cannakids®. Read more…


Relevium Technologies Inc. (TSXV:RLV,OTCQB:RLLVF;FWB:6BX)(the “Company” or “Relevium”), is pleased to announce that its OTC business has launched a new line of omega fish oils based formulations targeting inflammation, heart and vision care. High End Omega Based Product Line The Company has launched Read more…


Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), announced the re-pricing 12,398,500 warrants series 2017 with an original exercise price of $0.15 and expiring June 16, 2019 and 3,258,000 warrants of series 2016 with an original exercise price of $0.15 Read more…

Weevertising

Categorías